ArticlePLOS mental health2025
Persons suffering from severe and persistent mental illness with a persistent death wish: A cross-sectional study of the Reakiro care model.
Article in PLOS mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persons who suffer from unbearable psychiatric illness and a persistent death wish (chronic suicidality and/or a psychiatric euthanasia request) are an understudied subgroup of persons with Severe and Persistent Mental Illness (SPMI). They receive tailored care in Reakiro, a Belgian drop-in, care and expertise centre, where persons can enrol in existential counselling or peer support groups. Suicidology and psychiatric euthanasia literature identify several risk and protective factors that play a central role in the process of death wishes: meaning, hope, empowerment, suicidal ideation, existential anxiety, and psychosocial dysfunctioning. The aim of the study is to describe these central factors in this subgroup of persons attending Reakiro and compare them with other patient samples worldwide in order to position this subgroup in terms of severity of suffering. Another aim was to evaluate how the Reakiro care was experienced by the users. The Beck Scale for Suicide Ideation (M = 21.78, SD = 8.48), Netherlands Empowerment List (M = 113.39, SD = 20.42), Herth Hope Index (M = 24.15; SD = 5.40), Meaning In Life Measurement (M = 5.39, SD = 1.50), Existential Concerns Questionnaire (M = 62.13, SD = 12.11), and Outcome Questionnaire-45 (M = 98.93, SD = 20.50) showed very high suicidal ideation and severe suffering across all domains. The Reakiro sample scored almost exclusively worse on all factors compared with 20 samples worldwide. Users perceived Reakiro care as helpful, with individual counseling services as most helpful. Reakiro care seems to be a promising model appealing to this subgroup of persons with SPMI and a persistent death wish. These results should be interpreted with caution, as the cross-sectional design has several limitations. Replication or falsification with forthcoming longitudinal data is needed. Clinical implications of the results are discussed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.